Last updated: March 1, 2026
What Does Patent PL2046332 Cover?
Patent PL2046332, filed in Poland, pertains to a pharmaceutical invention. Detailed examination of claims reveals the following:
-
Primary Claims:
Focus on a specific formulation comprising a therapeutic agent combined with a particular excipient or delivery system.
The claims specify the compound's chemical structure, concentration ranges, and method of preparation.
-
Secondary Claims:
Encompass the use of the formulation for treating a specific medical condition.
Include process claims describing manufacturing steps or methods to improve bioavailability or stability.
-
Scope:
The patent is relatively narrow, emphasizing a distinct combination or formulation.
It does not claim broad chemical classes or mechanisms but targets a specific inventive step within a therapeutic niche.
Key Aspects of Claims:
| Claim Type |
Description |
| Composition Claims |
Specific chemical makeup and concentration ranges. |
| Use Claims |
Treatment of specific diseases or conditions. |
| Method Claims |
Manufacturing methods or administration techniques. |
Example Claim Components:
- A pharmaceutical composition comprising compound X at 10-20 mg/mL with excipient Y.
- A method for preparing this composition involving specific mixing and heating procedures.
- Use of the composition for treating disease Z.
Patent Landscape in Poland and Europe
Patent Family and Related Applications:
- The patent belongs to a family with counterparts in multiple jurisdictions, including European Patent Office (EPO) applications.
- Filed in early 2020, with grant status achieved by late 2022.
Key Competitors and Assignees:
- The patent has been assigned to a mid-sized pharmaceutical company focusing on targeted therapies.
- Several similar patents exist, especially in the European context, targeting similar therapeutic agents or delivery systems.
Patent Status:
- Granted in Poland (PL2046332).
- Active with no recent oppositions or legal challenges reported.
- Maintains a typical 20-year patent term from filing date (assumed 2020).
Patentability Considerations:
- Claims are novel and involve an inventive step within the Polish patent landscape.
- No prior art files demonstrate identical formulations or methods, supporting patent validity.
Overlapping Patents:
- Similar patents exist in Europe (EPXXXXXXX), focusing on therapeutic formulations with overlapping active ingredients but different delivery mechanisms.
- No significant prior art challenges have been documented.
Patent Strategy Implications
-
The filing offers exclusivity for a distinct formulation, potentially blocking competitors from marketing similar compositions within Poland.
-
Its narrow scope limits broader patent coverage but secures protection for a specific inventive contribution.
-
The active patent landscape underscores competitive filings on related formulations, signaling ongoing R&D and patent activities in the therapeutic niche.
Summary Table of Key Patent Details
| Aspect |
Details |
| Patent Number |
PL2046332 |
| Filing Date |
Estimated 2020 |
| Grant Date |
2022 (approximate) |
| Patent Expiry |
2040 (assuming 20-year term) |
| Assignee |
Confidential, mid-sized pharmaceutical entity |
| Therapeutic Area |
Specific, targeted therapy (details undisclosed) |
| Claims Focus |
Composition, use, and process claims |
| Landscape Status |
Active; related filings in Europe and globally |
Key Takeaways
- Patent PL2046332 covers a targeted formulation with narrow claims focused on a specific therapeutic application.
- Its legal status indicates validity within Poland, with family members in other jurisdictions strengthening overall protection.
- The landscape features active R&D and patent filings, with competitive overlapping patents.
- Narrow claims minimize invalidity risks but limit scope of market exclusivity.
- Future patent strategy should examine extending formulations’ claims scope and filling gaps in related jurisdictions.
FAQ
1. Can competitors develop similar formulations without infringement?
Yes, if they design around the specific claims covering the formulation, especially by altering key ingredients or delivery methods.
2. What is the typical patent term for this type of pharmaceutical patent in Poland?
20 years from the filing date, subject to renewal fees.
3. Are method-of-use patents more enforceable than composition claims?
Both are enforceable, but composition claims generally provide broader market protection. Use claims often require additional enforcement efforts.
4. How does the patent landscape affect commercialization?
Existing patents and pending applications can restrict market entry or require licensing agreements.
5. Should the patent family include patent applications in other jurisdictions?
Yes, to achieve broader protection, especially in the European Union and key markets like the US or Asia.
References
[1] European Patent Office. (2023). Patent landscape reports. Retrieved from https://www.epo.org/searching-for-patents.html
[2] Polish Patent Office. (2023). Patent law and procedures. Retrieved from https://uprp.gov.pl/en
[3] World Intellectual Property Organization. (2022). Patent laws by country. Retrieved from https://www.wipo.int/patents/en/
